| |
| |
|
| Insider
Information: |
Feczko Joseph M |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
548,855 |
|
|
Indirect Shares
|
22,293 |
|
|
| Direct
Value |
$12,012,229 |
|
|
|
Indirect Value
|
$624,427 |
|
|
| Total
Shares |
571,148 |
|
|
| Total
Value |
$12,636,655 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pfizer Inc |
PFE |
Senior Vice President |
2009-02-26 |
428,855 |
2009-02-26 |
22,293 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2015-06-17 |
120,000 |
|
0 |
Premium* |
|
|
Chemocentryx, Inc. |
CCXI |
Director |
2022-10-20 |
0 |
2013-09-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
officerTitle |
– – – |
2005-03-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
202,626 |
|
- |
|
| PFE |
Pfizer Inc |
officerTitle |
– – – |
2005-03-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
22,681 |
|
- |
|
| PFE |
Pfizer Inc |
officerTitle |
– – – |
2005-03-03 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
246,531 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2010-07-16 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| PFE |
Pfizer Inc |
Vice President |
• – – |
2006-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
54,050 |
307,298 |
|
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2007-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
47,030 |
362,621 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2007-04-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
800 |
2,925 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2007-04-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,300 |
348,772 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2008-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
22,562 |
369,055 |
0 |
- |
|
| PFE |
Pfizer Inc |
Senior Vice President |
• – – |
2009-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
60,172 |
446,259 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2011-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
40,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2012-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
85,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
100,000 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2014-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
110,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2015-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,027 |
37,027 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2015-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
120,000 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2016-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,795 |
48,822 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2017-05-25 |
4/A |
A |
$0.00 |
$0 |
D/D |
12,912 |
82,096 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2017-05-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,362 |
69,184 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2018-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
8,421 |
90,517 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,724 |
98,241 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2020-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,660 |
102,901 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
7,726 |
110,627 |
0 |
- |
|
| CCXI |
Chemocentryx, Inc. |
Director |
– • – |
2022-10-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(148,127) |
0 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2012-04-05 |
4 |
B |
$1.62 |
$32,400 |
D/D |
20,000 |
70,000 |
2.39 |
- |
|
44 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
